Table 3 |
|||||
|
Expression of EBV and Topo II∝ in relation to clinicopathological parameters in oral squamous cell carcinoma |
|||||
|
Parameter |
Total n. |
EBV |
P-value |
Topo II-∝ |
P-value |
|
|
|||||
|
Stage T |
22 |
||||
|
T1 |
8 |
29.24 ± 46.00 |
0.191 |
24.68 ± 5.96 |
0,038 |
|
T2 |
10 |
50.36 ± 30.71 |
26.38 ± 5.22 |
||
|
T3 |
4 |
45.48 ± 37.79 |
36.78 ± 9.39 |
||
|
|
|||||
|
N stage |
22 |
||||
|
N- |
9 |
23.59 ± 23.71 |
0.009 |
23.04 ± 3.95 |
0.002 |
|
N+ |
13 |
54.39 ± 26.62 |
30.84 ± 7.80 |
||
|
|
|||||
|
Differentiation |
22 |
||||
|
Well-diff. |
10 |
36.09 ± 22.37 |
0.208 |
22.40 ± 3.19 |
|
|
Moderate-diff |
8 |
41.15 ± 33.18 |
28.54 ± 4.84 |
0.000 |
|
|
Poorly-diff. |
4 |
57.33 ± 38.91 |
39.00 ± 6.45 |
||
|
|
|||||
|
Shamaa et al. Diagnostic Pathology 2008 3:45 doi:10.1186/1746-1596-3-45 |
|||||
